These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11826423)

  • 1. Variants of two major T cell epitopes within the hepatitis B surface antigen are not recognized by specific T helper cells of vaccinated individuals.
    Bauer T; Weinberger K; Jilg W
    Hepatology; 2002 Feb; 35(2):455-65. PubMed ID: 11826423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen.
    Rahman F; Dahmen A; Herzog-Hauff S; Böcher WO; Galle PR; Löhr HF
    Hepatology; 2000 Feb; 31(2):521-7. PubMed ID: 10655280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse.
    Böcher WO; Galun E; Marcus H; Daudi N; Terkieltaub D; Shouval D; Löhr HF; Reisner Y
    Hepatology; 2000 Feb; 31(2):480-7. PubMed ID: 10655274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination.
    Bauer T; Jilg W
    Vaccine; 2006 Jan; 24(5):572-7. PubMed ID: 16171909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.
    Böcher WO; Herzog-Hauff S; Schlaak J; Meyer zum Büschenfeld KH; Löhr HF
    Hepatology; 1999 Jan; 29(1):238-44. PubMed ID: 9862872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T-helper cell responses to a synthetic peptide derived from the hepatitis B surface antigen.
    Mishra A; Rao KV; Durgapal H; Manivel V; Panda SK
    Immunology; 1993 Jul; 79(3):362-7. PubMed ID: 7691722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus-reactive human T lymphocyte clones: antigen specificity and helper function for antibody synthesis.
    Celis E; Kung PC; Chang TW
    J Immunol; 1984 Mar; 132(3):1511-6. PubMed ID: 6198394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
    Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells.
    Bauer T; Günther M; Bienzle U; Neuhaus R; Jilg W
    Liver Transpl; 2007 Mar; 13(3):434-42. PubMed ID: 17318860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine.
    Gruener NH; Gerlach TJ; Ulsenheimer A; Diepolder HM; Wierenga E; Zachoval R; Heeg M; Pape GR; Jung MC
    Vaccine; 2007 Jun; 25(26):4960-6. PubMed ID: 17466417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variants.
    Schirmbeck R; Dikopoulos N; Kwissa M; Leithäuser F; Lamberth K; Buus S; Melber K; Reimann J
    Eur J Immunol; 2003 Dec; 33(12):3342-52. PubMed ID: 14635042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations.
    Cooreman MP; van Roosmalen MH; te Morsche R; Sünnen CM; de Ven EM; Jansen JB; Tytgat GN; de Wit PL; Paulij WP
    Hepatology; 1999 Nov; 30(5):1287-92. PubMed ID: 10534351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of T cell epitopes on hepatitis B surface antigen.
    Vento S
    Ann Ist Super Sanita; 1991; 27(1):37-40. PubMed ID: 1720295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens.
    Couillin I; Pol S; Mancini M; Driss F; Bréchot C; Tiollais P; Michel ML
    J Infect Dis; 1999 Jul; 180(1):15-26. PubMed ID: 10353856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single 10-residue pre-S(1) peptide can prime T cell help for antibody production to multiple epitopes within the pre-S(1), pre-S(2), and S regions of HBsAg.
    Milich DR; McLachlan A; Moriarty A; Thornton GB
    J Immunol; 1987 Jun; 138(12):4457-65. PubMed ID: 2438344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different immunogenicity of H-2 Kb-restricted epitopes in natural variants of the hepatitis B surface antigen.
    Schirmbeck R; Böhm W; Fissolo N; Melber K; Reimann J
    Eur J Immunol; 2003 Sep; 33(9):2429-38. PubMed ID: 12938219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides.
    Celis E; Ou D; Otvos L
    J Immunol; 1988 Mar; 140(6):1808-15. PubMed ID: 2450132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory functions of T- and accessory-cells for hepatitis B surface antigen induced specific antibody production and proliferation of human peripheral blood lymphocytes, in vitro.
    Hellström U; Sylvan S; Lundbergh P
    J Clin Lab Immunol; 1985 Apr; 16(4):173-81. PubMed ID: 3874965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg.
    Milich DR; McLachlan A; Chisari FV; Kent SB; Thorton GB
    J Immunol; 1986 Jul; 137(1):315-22. PubMed ID: 2423607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.